SANDRIDGE ENERGY INC (SD) Stock News

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. Ensign shares fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

A class action lawsuit has been filed against Verra Mobility Corporation for allegedly providing misleading statements about its relationship with Avis Budget Group. On May 26, 2026, Verra Mobility disclosed that Avis terminated its contract, resulting in an expected $135-145 million revenue reduction. The stock price fell 70.6% to $3.85 per share following the announcement. The deadline to join the class action is August 4, 2026.

ZenaTech completed its acquisition of Velocity Geomatics in July 2026, entering the Canadian oil and gas drone services market amid a 45% increase in crude oil prices and USD 500 billion in expected energy sector investments over the next decade. The company expects sustained demand for drone-based surveying, inspection, and environmental compliance services driven by increased producer cash flow and regulatory requirements.

Law firm Lowey Dannenberg is investigating Capricor Therapeutics for potential federal securities violations following disclosure that FDA briefing materials relied on an outdated statistical analysis plan for its Deramiocel therapy BLA. The stock fell 64% after the disclosure, and an FDA Advisory Committee subsequently voted against the drug's effectiveness for cardiomyopathy in DMD patients.

Hagens Berman has opened an investigation into Capricor Therapeutics following a 64% stock collapse on July 27, 2026. The FDA's briefing document revealed that the company's lead drug candidate Deramiocel failed to meet pre-specified primary and secondary efficacy endpoints in the Phase 3 HOPE-3 trial, contradicting Capricor's December 2025 announcement of 'positive' results. The investigation focuses on whether Capricor misled investors about trial efficacy and undisclosed changes to the statistical analysis plan.

Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. (NASDAQ: CRMT) for allegedly issuing materially misleading business information. The investigation was prompted by the company's September 4, 2025 earnings report showing a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, which caused the stock to plunge 18.2%. The firm is preparing a class action lawsuit to recover investor losses.

A class action lawsuit has been filed against EquipmentShare.Com Inc (NASDAQ: EQPT) on behalf of investors who purchased stock during its IPO on January 23, 2026 through June 23, 2026. The lawsuit was triggered by a June 24, 2026 report alleging undisclosed related party transactions netting founders at least $77 million, causing the stock to decline 6.62% that day and an additional 11.7% the following day. The lead plaintiff deadline is September 21, 2026.

Law firm Robbins Geller has filed class action lawsuits against GRAIL, Inc., GPGI, Inc., and Wix.com Ltd., alleging that executives made false and misleading statements to investors. GRAIL investors can seek lead plaintiff status by August 4, 2026, following a 50% stock price decline after the company failed to achieve primary endpoints in its NHS-Galleri cancer screening trial.

Law firm Kessler Topaz Meltzer & Check is investigating Celcuity Inc. for potential securities law violations following the company's announcement of a delayed drug launch for its FDA-approved breast cancer therapy Revtorpyk. The delayed launch timeline, announced on July 14, 2026, fell short of analyst expectations and triggered a 17% stock price decline. The firm is encouraging investors who suffered losses to contact them regarding potential legal rights.

Kaplan Fox has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) alleging that the company misrepresented demand for optical wavelengths and inflated order backlogs during the Class Period (February 29, 2024 - May 1, 2026). The complaint states that the publicized backlog was largely illusory and did not convert to paying customers. Following CEO David Schaeffer's May 4, 2026 admission that customers were delaying wavelength acceptance, Cogent's stock fell 29% to $16.37 per share. The deadline for investors to serve as lead plaintiffs is September 21, 2026.

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) following a whistleblower complaint alleging accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

A securities fraud class action lawsuit has been filed against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) for allegedly making material misstatements about its optical wavelength services backlog and customer demand. The lawsuit covers investors who purchased CCOI stock between February 29, 2024 and May 1, 2026. The stock declined 29% on May 4, 2026, following disclosure of wavelength underperformance and customer acceptance delays.

Grabar Law Office announced investigations into multiple publicly traded companies on behalf of shareholders, alleging breaches of fiduciary duties and securities law violations. The investigations cover Erasca (misleading statements about ERAS-0015 drug candidate and patent infringement), Insulet (defective manufacturing controls leading to product recalls), New Era Energy & Digital (overstated project progress and fraudulent oil-and-gas schemes), Power Solutions International (overstated sales demand and understated manufacturing costs), Hub Group, Planet Fitness, Primoris Services, EquipmentShare.com, GPGI, Photronics, and Via Transportation. Shareholders who meet specific holding criteria may seek damages and corporate governance reforms at no cost.

Syntec Optics (NASDAQ: OPTX) announced a major production order to expand its space optics product line, focusing on advanced collision avoidance systems for satellites in low Earth orbit. The company will manufacture specialized optics to help satellites detect and avoid space debris traveling at extreme speeds. Syntec leverages its existing expertise in high-precision optics manufacturing and satellite communication systems to address the growing space traffic management challenge.

The global AI in medical coding market is valued at USD 3 billion in 2025 and is expected to grow to USD 10.6 billion by 2035, expanding at a 13.5% CAGR. Key market players include 3M Company, Optum Inc., Nuance Communications Inc., Oracle Health, and others. The market growth is driven by increasing demand for automated code assignment, fraud detection, and compliance monitoring across healthcare providers and payers.

The Rosen Law Firm is investigating potential securities claims against UP Fintech Holding Limited (TIGR) following a May 22, 2026 Reuters report that China announced a crackdown on cross-border securities trading. The regulatory action accused Tiger, Futu, and Longbridge of illegally soliciting business without proper onshore licenses, causing TIGR shares to fall 25.3% in premarket trading. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

Firefly Neuroscience (NASDAQ: AIFF) and Next Health announced a strategic partnership to launch a precision cognitive health platform combining Firefly's FDA-cleared AI-powered EEG/ERP brain biomarker technology with personalized cognitive peptide protocols. The collaboration follows an FDA Advisory Committee's recommendation to ease compounding restrictions for six peptides, including Epitalon and Semax, which have shown potential neuroprotective and cognitive-supportive properties in scientific literature.

The global ultrasonic aspirator market is valued at USD 194.03 million in 2025 and is projected to reach USD 376.32 million by 2035, growing at a CAGR of 6.87%. The U.S. market is expected to grow from USD 67.49 million to USD 118.90 million by 2035, driven by increasing adoption of advanced surgical technologies, rising neurosurgery procedures, and growing demand for minimally invasive surgeries. North America leads the market with 39.80% share, while Asia-Pacific registers the fastest growth at 8.83% CAGR.

The global pharmaceutical surfactants market was valued at USD 4.5 billion in 2025 and is projected to reach USD 6.93 billion by 2035, growing at a CAGR of 4.42%. The market is driven by increasing demand for improved drug formulation, delivery systems, and expanding healthcare infrastructure. Non-ionic surfactants currently hold the largest market share, while Asia-Pacific is expected to be the fastest-growing region.

Rosen Law Firm is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potentially issuing materially misleading business information to investors. The investigation was triggered by a short-seller report from Hunterbrook alleging that Ensign's profitability model relies on reducing patient care quality and manipulating quality scores. Following the report's release on June 8, 2026, Ensign's stock price declined 8.15%. The firm is preparing a class action lawsuit and inviting affected investors to join.

A securities class action has been filed against ZoomInfo Technologies Inc. (NASDAQ: GTM) for allegedly making materially false or misleading statements regarding its growth prospects, revenue outlook, customer retention, and AI product expansion between November 3, 2025 and May 11, 2026. The company allegedly failed to disclose slowing growth, weakening customer retention, challenges with legacy subscription products, and customer migration to consumption-based models. ZoomInfo's stock fell to $4.06 per share on May 12, 2026, following the disclosure of deteriorated growth outlook and reduced full-year 2026 guidance. Investors who purchased securities during the class period may be eligible to participate, with an August 24, 2026 deadline to seek lead plaintiff appointment.

A securities class action has been filed against PicS N.V. (NASDAQ: PICS) alleging that its January 2026 IPO Registration Statement and Prospectus contained materially false or misleading statements regarding credit risk management and loan portfolio quality. The company failed to disclose deficiencies in credit evaluation procedures, loan reclassifications, and deteriorating borrower credit quality. Following subsequent disclosures in March and June 2026, PicS stock declined over 50% from its $19.00 IPO price to below $9.00 per share. Investors who purchased shares in the IPO may be eligible to participate in the lawsuit with an August 4, 2026 deadline to seek lead plaintiff appointment.

A securities class action has been filed against Futu Holdings Limited (NASDAQ: FUTU) for allegedly making materially false or misleading statements regarding regulatory compliance and financial reporting. The company failed to disclose non-compliance with China Securities Regulatory Commission requirements, unlicensed business operations in mainland China, and the risk of significant regulatory penalties. On May 28, 2026, Futu disclosed proposed penalties totaling approximately RMB1.85 billion, causing the stock to decline 4.8%. Investors who purchased FUTU securities between May 24, 2023 and May 27, 2026 may be eligible to participate in the lawsuit.

The global isobutanol market is projected to grow from USD 0.74 billion in 2025 to USD 1.89 billion by 2035, representing a 38% CAGR. Growth is driven by increasing demand for sustainable biofuel components, bio-based chemicals, and applications in coatings, solvents, and pharmaceuticals. Bio-based isobutanol is the fastest-growing segment, with Asia Pacific leading regional growth due to industrialization and green chemistry initiatives.

Kaplan Fox has filed a class action lawsuit against PicS N.V. on behalf of IPO investors, alleging the company made false statements regarding its credit evaluation procedures and financial condition. The lawsuit claims PicS failed to disclose a December 2025 reclassification of R$590 million in credit exposures to its highest risk category and undisclosed credit quality deterioration. PicS stock has declined over 50% from its $19 IPO price in January 2026 to below $9 per share by June 2026.

A securities class action lawsuit has been filed against Lucid Group on behalf of investors who purchased shares between February 25, 2026 and April 13, 2026. The lawsuit alleges that Lucid made false and misleading statements regarding its manufacturing capabilities and financial performance. The company disclosed a supplier quality issue that disrupted Gravity deliveries for 29 days, resulting in significant stock price declines of 11.35% and 4.76% following separate announcements in early April 2026. The deadline to serve as lead plaintiff is July 28, 2026.

Grabar Law Office has initiated investigations on behalf of shareholders of four NASDAQ-listed companies: Cogent Communications (CCOI), EquipmentShare (EQPT), Photronics (PLAB), and PROCEPT BioRobotics (PRCT). The investigations allege breaches of fiduciary duties, including misrepresentation of business fundamentals, undisclosed related-party transactions, false demand statements, and artificially inflated sales figures. Shareholders who purchased shares before specified dates and still hold them may seek corporate reforms and damages at no cost.

The global blowing agent market is projected to grow from USD 1.79 billion in 2025 to USD 2.94 billion by 2035, driven by increasing demand for eco-friendly foam insulation, regulatory requirements to ban high-GWP compounds, and energy-efficient building construction. Chemical blowing agents dominate with 51.8% market share, while HFO technology is the fastest-growing segment. North America leads with 32.5% market share, with the U.S. market expected to reach USD 0.56 billion by 2035, while Europe is projected to reach USD 0.66 billion.

The Rosen Law Firm is investigating potential securities claims against Wise Group plc (NASDAQ: WSE) following allegations of materially misleading business information. The investigation was prompted by a Wall Street Journal article on June 1, 2026, reporting that Brussels' public prosecutor is investigating Wise Group for potential money laundering offenses. The stock fell sharply following the news. Investors who purchased Wise Group securities may be eligible for compensation through a class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of funds. Ensign shares fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.